PNS249 What are the priority patient engagement activities in medicines development? Results of a global multi-stakeholder consultation

S. Skovlund; O. V. Gorbenko; D. P. Richards; B. Nafria; L. Delbecque; K. H. Deane; K. B. Schroeder; I. Sargeant; A. M. Hamoir

doi:10.1016/j.jval.2019.04.1604

PNS249 What are the priority patient engagement activities in medicines development? Results of a global multi-stakeholder consultation

S. Skovlund, O. V. Gorbenko, D. P. Richards, B. Nafria, L. Delbecque, K. H. Deane, K. B. Schroeder, I. Sargeant, A. M. Hamoir

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S328
Journal	Value in Health
Volume	22
Issue number	2
DOIs	https://doi.org/10.1016/j.jval.2019.04.1604
Publication status	Published - 1 May 2019

Access to Document

10.1016/j.jval.2019.04.1604Licence: Other

Cite this

@article{4f05d0be08404938a35b06fa821d4d73,

title = "PNS249 What are the priority patient engagement activities in medicines development? Results of a global multi-stakeholder consultation",

author = "S. Skovlund and Gorbenko, {O. V.} and Richards, {D. P.} and B. Nafria and L. Delbecque and Deane, {K. H.} and Schroeder, {K. B.} and I. Sargeant and Hamoir, {A. M.}",

year = "2019",

month = may,

day = "1",

doi = "10.1016/j.jval.2019.04.1604",

language = "English",

volume = "22",

pages = "S328",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - PNS249 What are the priority patient engagement activities in medicines development? Results of a global multi-stakeholder consultation

AU - Skovlund, S.

AU - Gorbenko, O. V.

AU - Richards, D. P.

AU - Nafria, B.

AU - Delbecque, L.

AU - Deane, K. H.

AU - Schroeder, K. B.

AU - Sargeant, I.

AU - Hamoir, A. M.

PY - 2019/5/1

Y1 - 2019/5/1

U2 - 10.1016/j.jval.2019.04.1604

DO - 10.1016/j.jval.2019.04.1604

M3 - Article

VL - 22

SP - S328

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 2

ER -